The story of Viagra presents a complex picture for investors. While the initial introduction generated massive returns, the end of its exclusive rights opened the door to off-brand versions, dramatically eroding revenue. This creates a specific challenge for firms banking on related blockbuster products, suggesting that a unquestioning stake in the

The story of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, yielding billions in revenue , its exclusivity period created a wave of lower-priced alternatives , significantly diminishing its dominance. While some businesses may try to capitalize on similar conditions , the current landsca